Literature DB >> 27073575

Philadelphia chromosome-negative non-Hodgkin's lymphoma occurring in Philadelphia chromosome-positive chronic myeloid leukemia: A case report and literature review.

Zheng-Lei Shen1, Lie-Fen Yin2, Wen-Wen Mao3, Jin Liang1, Ling Yang2.   

Abstract

The current study reports the case of a patient with Philadelphia chromosome-negative (Ph-) non-Hodgkin's lymphoma (NHL) and chronic phase (CP) Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) that also possessed characteristic enlarged lymph nodes. A lymph node biopsy resulted in the diagnosis of CP-CML, in addition to T-lymphoblastic cell NHL with negative break point cluster/Abelson tyrosine kinase fusion genes in the lymph node of the patient, which was diagnosed as Ph- NHL. A review of the literature was performed in the present study to investigate the genetic differences between Ph- NHL and Ph+ NHL in patients with CML. The median age of patients with NHL and CML was 41 years. The follow-up time of patients with Ph+ NHL was significantly shorter (mean, <6 months) compared to the follow-up time of patients with Ph- NHL (mean, >15 months). Therefore the present study concludes that Ph+ NHL may be more aggressive compared with Ph+ NHL. The present study suggests that additional studies are required to assess the clinical and genetic characteristics of NHL patients with CML.

Entities:  

Keywords:  chronic myelogenous leukemia; fusion gene; non-Hodgkin's lymphomas; philadelphia chromosome

Year:  2016        PMID: 27073575      PMCID: PMC4812197          DOI: 10.3892/ol.2016.4304

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

Review 1.  Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.

Authors:  R Ichinohasama; I Miura; N Takahashi; T Sugawara; E Tamate; K Endoh; F Endoh; H Naganuma; J F DeCoteau; J D Griffin; M E Kadin; K Ooya
Journal:  Leukemia       Date:  2000-01       Impact factor: 11.528

2.  Imatinib mesylate-induced long-term remission in extra-medullary T-cell lymphoid blastic phase of chronic myelogenous leukemia.

Authors:  Jan A Burger; Annette Schmitt-Gräff; Andrea Bürkle; Lysann Seiler; Jürgen Finke
Journal:  Leuk Lymphoma       Date:  2006-11

3.  T-lymphoblastic transformation of chronic myelocytic leukemia following T-lymphoblastic and myeloblastic biphenotypic crisis in the lymph nodes with rearrangement of bcr and TCR-beta genes.

Authors:  Y Hirose; J Tachibana; T Takiguchi; E Tatsumi; S Konda
Journal:  Eur J Haematol       Date:  1990-11       Impact factor: 2.997

4.  Megakaryocytic blast crisis at presentation in a pediatric patient with chronic myeloid leukemia.

Authors:  Ali Al-Shehri; Amal Al-Seraihy; Tarek M Owaidah; Asim F Belgaumi
Journal:  Hematol Oncol Stem Cell Ther       Date:  2010

5.  Long-term remission of T-lymphoid extramedullary blast crisis of chronic myelogenous leukemia following allogeneic bone marrow transplantation.

Authors:  E Montefusco; F R Mauro; F Lo Coco; B Rondinelli; W Arcese; A Tabilio; B Monarca; G Alimena; F Mandelli
Journal:  Haematologica       Date:  1990 Jul-Aug       Impact factor: 9.941

6.  Nodal T cell blast crisis in chronic myeloid leukemia.

Authors:  G Lucero; V Birman; E Colimodio; C M Bertinetti; N Kotliar; P Murolo; O Irusta; J Klimovsky; B Koziner
Journal:  Leuk Lymphoma       Date:  2000-10

7.  Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate.

Authors:  Mitsuhiro Matsuda; Yasuyoshi Morita; Takahiro Shimada; Junichi Miyatake; Chikara Hirase; Miyako Tanaka; Yoichi Tatsumi; Yasuhiro Maeda; Akihisa Kanamaru
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

8.  Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.

Authors:  K Ganessan; Ruchika Goel; Kamlesh Kumar; Sameer Bakhshi
Journal:  Pediatr Hematol Oncol       Date:  2007 Apr-May       Impact factor: 1.969

9.  Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma.

Authors:  G Leone; L M La Rocca; L Teofili; E De Candia; R Landolfi; S Sica; G Zini; M Zollino; A Tabilio
Journal:  Haematologica       Date:  1992 Jul-Aug       Impact factor: 9.941

Review 10.  Practical aspects of the treatment of chronic myelogenous leukemia with imatinib mesylate.

Authors:  Jeffrey A Zonder; Charles A Schiffer
Journal:  Curr Hematol Rep       Date:  2003-01
View more
  2 in total

1.  Case report; meta-synchronous triple malignancy in primary diagnosed CML patient.

Authors:  Esraa Jamal; Shaimaa El-Ashwah; Mohamed A Ebrahim; Marwa Ma Zaki; Layla'M Saleh; Adel El-Badrawy; Emad Azmy
Journal:  Am J Blood Res       Date:  2020-04-15

2.  Analyses and treatment of simultaneous bi-lineage malignancies of myeloid leukemia and lymphoma: Two case reports and a literature review.

Authors:  Xiaorui Fu; Yufeng Shang; Lei Zhang; Ling Li; Xin Li; Xinhua Wang; Zhenchang Sun; Mingzhi Zhang
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.